Monetary benefit is measured in which of the following?
How is the Human Poverty Index 2 (HPI-2) different from the Human Poverty Index 1 (HPI-1), as described by the UNDP?
What is the most cost-effective method of family planning?
Which management technique is the most promising tool for application in the health field?
When the economic benefits of any program are compared with the cost of the program, it is called as what?
Which of the following is NOT a feature of cost accounting?
What is the primary purpose of loans provided by the World Bank?
Measurement of output in terms of results achieved is:
The assessment of a health programme where the benefit is expressed in terms of results achieved is called?
What is the most cost-effective way to approach a project?
Explanation: ### Explanation In health economics, different types of evaluation methods are used to compare the costs and consequences of healthcare interventions. **Why Cost-Benefit Analysis (CBA) is correct:** Cost-Benefit Analysis is the only method where **both the costs and the outcomes (benefits) are measured in monetary units** (e.g., Dollars, Rupees). This allows policymakers to calculate the "Net Present Value" or the "Benefit-Cost Ratio." Because everything is converted into currency, CBA allows for the comparison of health programs with non-health programs (e.g., comparing a vaccination drive to building a new highway). **Analysis of Incorrect Options:** * **Cost-Effectiveness Analysis (CEA):** Here, costs are measured in monetary terms, but benefits are measured in **natural units** (e.g., years of life saved, number of cases prevented, or reduction in blood pressure). It is the most common method used in healthcare. * **Network Analysis:** This is a management tool (including PERT and CPM) used for **planning and controlling** complex projects by identifying the sequence of activities. It does not measure monetary benefits of health outcomes. * **Program Budgeting System:** This is a **financial management technique** used for resource allocation and planning within an organization based on specific goals rather than just line-item expenditures. **High-Yield Pearls for NEET-PG:** * **Cost-Utility Analysis (CUA):** A special type of CEA where benefits are measured in **Quality-Adjusted Life Years (QALYs)** or Disability-Adjusted Life Years (DALYs). * **Cost-Minimization Analysis (CMA):** Used when two interventions have **equal outcomes**, so only the costs are compared to find the cheapest option. * **Input** in all health economic evaluations is always measured in **Money**. The difference lies solely in how the **Output** is measured.
Explanation: The **Human Poverty Index (HPI)** was introduced by the UNDP to measure deprivation in the same three dimensions as the Human Development Index (HDI): longevity, knowledge, and standard of living. However, the UNDP distinguishes between developing countries (HPI-1) and developed (OECD) countries (HPI-2). ### **Why Option B is Correct** While HPI-1 focuses on absolute poverty and basic survival, **HPI-2** is designed for high-income countries where poverty is often relative. To reflect the complexities of developed societies, HPI-2 includes a fourth dimension: **Social Exclusion**. This is measured by the **rate of long-term unemployment** (12 months or more), reflecting the psychological and social isolation that occurs when individuals are marginalized from the labor market. ### **Analysis of Incorrect Options** * **Option A (Financial Inclusion):** While important for economic development, it is not a formal component of the HPI-2 metric. * **Option C & D (Geriatric Empowerment/Occupational Health):** These are specific health indicators but are not used as composite indicators in the UNDP’s poverty indices. ### **High-Yield NEET-PG Pearls** * **HPI-1 (Developing Countries):** Measures (1) Probability at birth of not surviving to age 40, (2) Adult illiteracy rate, and (3) Unweighted average of population without access to safe water and children underweight for age. * **HPI-2 (Selected OECD Countries):** Measures (1) Probability at birth of not surviving to age 60, (2) Percentage of adults lacking functional literacy skills, (3) Population below 50% of median income, and (4) **Social Exclusion** (Long-term unemployment). * **Current Status:** Note that since 2010, the HPI has been largely replaced by the **Multidimensional Poverty Index (MPI)** in UNDP reports.
Explanation: ### Explanation **Correct Option: A. Vasectomy** In health economics, **Cost-Effectiveness Analysis (CEA)** measures the cost of an intervention against its health outcomes (e.g., cost per pregnancy averted). **Vasectomy** is considered the most cost-effective method of family planning globally. This is because it is a one-time, permanent procedure with a very low failure rate (Pearl Index ~0.1–0.15). Unlike temporary methods, it requires no recurring costs for supplies, follow-up injections, or daily compliance, making the long-term cost per year of protection significantly lower than any other method. **Why Incorrect Options are Wrong:** * **B. Barrier method (Condoms):** While the unit cost is low, the cumulative cost over a reproductive lifetime is high. Furthermore, high "user-failure" rates lead to unintended pregnancies, increasing the overall economic burden. * **C. DMPA (Injectables):** These require recurring costs every 3 months for the drug and the healthcare provider's time for administration, making them more expensive over time than a one-time surgical procedure. * **D. Oral pills:** These require daily compliance and monthly procurement. The high recurring cost and the risk of failure due to missed pills make them less cost-effective than permanent sterilization. **High-Yield Clinical Pearls for NEET-PG:** * **Most Effective Method:** Implants and Vasectomy (lowest failure rates). * **NSV (No-Scalpel Vasectomy):** The preferred technique due to fewer complications (hematoma/infection) compared to conventional vasectomy. * **Post-Vasectomy Advice:** It is not immediately effective. A man is considered sterile only after **3 months** or after **20 ejaculations**, confirmed by a sperm-free semen analysis. * **Cost-Benefit vs. Cost-Effectiveness:** Cost-benefit measures outcomes in monetary terms, while cost-effectiveness measures outcomes in natural units (e.g., births averted).
Explanation: **Explanation:** In health management, **Cost-Effectiveness Analysis (CEA)** is considered the most promising and widely used tool because it measures outcomes in **natural health units** (e.g., lives saved, cases prevented, years of life gained, or reduction in blood pressure) rather than monetary terms. Since the primary goal of healthcare is improving health outcomes rather than generating profit, CEA allows administrators to compare different interventions for the same condition to determine which achieves the best clinical result for the least expenditure. **Analysis of Options:** * **Cost-Benefit Analysis (CBA):** This measures both inputs and outcomes in **monetary terms**. While useful for cross-sector comparisons (e.g., comparing a road project to a hospital), it is difficult and often ethically controversial to assign a specific dollar value to a human life or "health." * **Cost Accounting:** This is a basic administrative tool used to calculate the actual cost of providing a specific service (e.g., the cost of one X-ray). It provides data for budgeting but does not evaluate the health impact or efficiency of the service. * **Input-Output Analysis:** This focuses on the relationship between the resources put into a system and the resulting products. It is more suited for industrial production and macroeconomics than for the nuanced clinical outcomes of the health sector. **High-Yield Pearls for NEET-PG:** * **CEA:** Outcomes are in **physical units** (e.g., "Cost per infant death averted"). * **CBA:** Outcomes are in **monetary units** (e.g., "For every $1 spent, $5 are saved"). * **Cost-Utility Analysis (CUA):** A specialized form of CEA where outcomes are measured in **Quality-Adjusted Life Years (QALYs)** or **Disability-Adjusted Life Years (DALYs)**. * **Network Analysis:** Includes PERT (Program Evaluation and Review Technique) and CPM (Critical Path Method), used for project scheduling and time management.
Explanation: ### Explanation **1. Why Cost-Benefit Analysis (CBA) is Correct:** In **Cost-Benefit Analysis**, both the inputs (costs) and the outcomes (benefits) are measured in **monetary terms** (e.g., dollars or rupees). It allows decision-makers to calculate the "Net Present Value" or the "Benefit-Cost Ratio." If the economic benefit exceeds the cost, the program is considered worthwhile. It is the only method that allows for a direct comparison between programs in different sectors (e.g., comparing a vaccination program vs. building a new highway). **2. Why the Other Options are Incorrect:** * **B. Cost-Effective Analysis (CEA):** Here, costs are measured in monetary terms, but outcomes are measured in **natural units** (e.g., number of lives saved, cases prevented, or years of life gained). It is used to compare different ways of achieving the same goal. * **C. Cost Accounting:** This is a purely administrative process of recording and analyzing all costs incurred in a business or project to improve financial management. It does not measure health outcomes or benefits. * **D. Input-Output Analysis:** This is a macroeconomic tool used to describe the flow of goods and services between different sectors of an economy. It focuses on how the output of one industry becomes the input for another. **3. High-Yield Clinical Pearls for NEET-PG:** * **Cost-Utility Analysis (CUA):** A specialized form of CEA where outcomes are measured in terms of "quality of life," most commonly using **QALYs** (Quality Adjusted Life Years) or **DALYs** (Disability Adjusted Life Years). * **Efficiency:** Defined as the optimal use of resources to yield maximum output (doing things right). * **Effectiveness:** The extent to which a program produces a desired result under real-world conditions. * **Efficacy:** The extent to which a program produces a result under ideal, controlled conditions (e.g., a randomized controlled trial).
Explanation: **Explanation:** In Health Economics, it is crucial to distinguish between **Cost Accounting** and **Cost-Effectiveness/Benefit Analysis**. **1. Why Option D is the correct answer:** Cost accounting is strictly an internal process focused on the **input** side of a program. It involves the systematic recording and analysis of all expenditures incurred to provide a service. **Benefit expressed as results achieved** refers to the **output** or outcome of a program. This is a feature of *Cost-Effectiveness Analysis* (where outcomes are measured in natural units like lives saved) or *Cost-Benefit Analysis* (where outcomes are measured in monetary terms), rather than cost accounting itself. **2. Why the other options are incorrect:** * **Option A (Cost control):** One of the primary objectives of cost accounting is to identify areas of wastage and implement measures to reduce expenses without compromising quality. * **Option B (Planning and allocation):** By analyzing past expenditures, cost accounting provides the data necessary for administrators to plan future budgets and allocate human and financial resources efficiently. * **Option C (Cost structure of program):** Cost accounting breaks down expenses into categories (e.g., capital costs vs. recurrent costs, or direct vs. indirect costs), which defines the overall cost structure. **High-Yield Clinical Pearls for NEET-PG:** * **Cost-Benefit Analysis (CBA):** Both inputs and outputs are measured in **monetary units** (e.g., Dollars/Rupees). * **Cost-Effectiveness Analysis (CEA):** Inputs are monetary, but outputs are measured in **natural units** (e.g., number of cases prevented, years of life gained). * **Cost-Utility Analysis (CUA):** A specialized form of CEA where the outcome is measured in **Quality Adjusted Life Years (QALYs)** or **DALYs**. * **Cost-Accounting:** Focuses solely on the **process and input** (expenditure analysis).
Explanation: ### Explanation **1. Why the Correct Answer is Right:** The **World Bank** (International Bank for Reconstruction and Development) is a specialized agency of the United Nations. Its primary objective is to provide long-term financial assistance to developing countries to **promote economic growth** and reduce poverty. In the context of health, the World Bank views health as a form of "human capital." It provides loans for large-scale structural projects (e.g., strengthening health systems, water and sanitation, and population control) because a healthy population is more productive, thereby driving the national economy. **2. Analysis of Incorrect Options:** * **Options B & C:** Funding specific medical equipment like cobalt therapy units or microscopes is typically the domain of specialized technical agencies or bilateral aid. For example, the **International Atomic Energy Agency (IAEA)** often assists with radiotherapy equipment, and **UNICEF** or **WHO** might facilitate diagnostic tools for specific disease programs like TB. The World Bank focuses on broad sectoral reforms rather than micro-level equipment procurement. * **Option D:** While the World Bank aims for "shared prosperity," its core mandate is economic development. "Social justice" is a broader political and legal concept often associated with human rights organizations or specific UN mandates (like the ILO for labor justice), rather than the primary fiscal objective of World Bank loans. **3. High-Yield Facts for NEET-PG:** * **Headquarters:** Washington D.C., USA. * **Health Focus:** Most World Bank health loans are directed toward **Population Control (Family Planning)**, Nutrition, and Water/Sanitation. * **The "Twin Goals":** To end extreme poverty and promote shared prosperity. * **Comparison:** While **WHO** provides *technical* leadership and sets standards, the **World Bank** provides the *financial* muscle for large-scale health infrastructure.
Explanation: ### Explanation In Health Economics, the choice of analysis depends on how the outcomes (results) are measured. **Why Cost-Effectiveness Analysis (CEA) is correct:** CEA is used when the output or results are measured in **natural units** or physical terms (e.g., number of lives saved, cases prevented, reduction in blood pressure, or years of life gained). It compares the relative costs and outcomes of two or more courses of action to achieve a specific health objective. It answers the question: "Which intervention provides the most health benefit for every dollar spent?" **Analysis of Incorrect Options:** * **A. Cost-Benefit Analysis (CBA):** In CBA, both the inputs (costs) and the outputs (results) are measured in **monetary terms** (e.g., dollars or rupees). It is used to determine if the financial gain of a program outweighs its cost. * **C. Systems Analysis:** This is a broad management tool used to analyze the entire structure and function of an organization to improve decision-making and resource allocation. It is not a specific economic evaluation of health outcomes. * **D. Network Analysis:** This refers to project management techniques like **PERT** (Program Evaluation and Review Technique) and **CPM** (Critical Path Method). These are used for planning and scheduling complex projects, not for measuring health results against costs. **High-Yield NEET-PG Pearls:** 1. **Cost-Utility Analysis (CUA):** A specialized form of CEA where results are measured in terms of "quality of life," typically using **QALYs** (Quality Adjusted Life Years) or **DALYs** (Disability Adjusted Life Years). 2. **Cost-Minimization Analysis (CMA):** Used when the outcomes of two interventions are **equal**, so the focus is solely on finding the least expensive option. 3. **Input** is always measured in terms of **Money** (Cost) in all these analyses.
Explanation: ### Explanation **Cost-Effective Analysis (CEA)** is the correct answer because it measures the outcome of a health program in terms of **natural units or clinical results achieved** (e.g., number of lives saved, cases prevented, years of life gained, or reduction in blood pressure). In CEA, the inputs are measured in monetary terms, but the benefits are expressed in non-monetary, objective health outcomes. This is the most common method used in public health to compare different interventions for the same condition. #### Analysis of Incorrect Options: * **A. Cost-Benefit Analysis (CBA):** In CBA, both the costs and the benefits are expressed in **monetary terms** (dollars/rupees). This allows for a direct comparison of programs across different sectors (e.g., comparing a vaccination drive to building a highway). * **C. Cost Accounting:** This is a management process used to track and calculate the total expenditure involved in producing a service or product. It does not measure health outcomes or benefits. * **D. Cost Containment:** This refers to policies or strategies aimed at controlling or reducing health expenditure without necessarily focusing on the measurement of outcomes. #### High-Yield Pearls for NEET-PG: * **Cost-Utility Analysis (CUA):** A specialized form of CEA where the benefit is measured in terms of "quality of life," typically using **QALYs** (Quality Adjusted Life Years) or **DALYs** (Disability Adjusted Life Years). * **Cost-Minimization Analysis (CMA):** Used when two interventions have **equal outcomes**, and the goal is simply to find the least expensive option. * **Key Distinction:** If the question mentions "expressed in monetary terms," choose **CBA**. If it mentions "natural units/results," choose **CEA**.
Explanation: **Explanation:** In health management and economics, **Cost Analysis** is the fundamental process of evaluating the inputs (resources) required to achieve a specific output (health goal). It is considered the most cost-effective way to approach a project because it allows managers to quantify the financial implications of different strategies, ensuring that resources are allocated to interventions that provide the maximum health benefit for the least expenditure. By identifying and comparing costs, administrators can eliminate wasteful spending and prioritize high-impact programs. **Analysis of Options:** * **Network Analysis (PERT/CPM):** This is a management tool used for **planning and scheduling** complex projects. It focuses on the sequence of events and time management (e.g., identifying the "critical path") rather than primarily on financial efficiency. * **System Analysis:** This is a broad, holistic approach used to understand the interdependencies within an organization. While it helps in decision-making and problem-solving, it is a **structural/functional assessment** rather than a specific tool for cost-effectiveness. * **Field Analysis:** This generally refers to situational assessments or data collection in a natural setting. It is a method of **observation or research** but does not inherently provide a framework for economic efficiency. **High-Yield Clinical Pearls for NEET-PG:** * **Cost-Benefit Analysis:** Benefits are measured in **monetary terms** (e.g., dollars saved). * **Cost-Effectiveness Analysis:** Benefits are measured in **natural units** (e.g., lives saved, cases prevented). * **Cost-Utility Analysis:** Benefits are measured in **Quality-Adjusted Life Years (QALYs)**. * **Input-Output Analysis:** A technique used to assess the relationship between the resources put into a system and the resulting products or services.
Explanation: ### Explanation The question refers to the **Human Poverty Index (HPI)**, introduced by the UNDP. The HPI was designed to measure deprivation in the same three basic dimensions of human development as the Human Development Index (HDI). **1. Why "Income" is the correct answer:** The Human Poverty Index focuses on **deprivation in human life** rather than just financial lack. While income is a common measure of poverty in traditional economic terms, it is **not** a direct component of the HPI. The HPI measures the *denial* of opportunities and choices most basic to human development. **2. Analysis of Options (Components of HPI):** The HPI-1 (for developing countries) consists of three dimensions: * **Long Life (Option A):** Measured by vulnerability to death at a relatively early age (specifically, the probability at birth of not surviving to age 40). * **Knowledge (Option B):** Measured by exclusion from the world of reading and communications (specifically, the adult illiteracy rate). * **Standard of Living (Option D):** Measured by lack of access to overall economic provisioning. This is represented by a composite of: * Percentage of the population without sustainable access to an improved water source. * Percentage of children underweight for their age. **3. High-Yield Facts for NEET-PG:** * **HDI vs. HPI:** While HDI measures *average achievement*, HPI measures *deprivation* in the same dimensions. * **MPI (Multidimensional Poverty Index):** In 2010, the HPI was replaced by the MPI. The MPI uses 10 indicators across three dimensions: **Health** (Nutrition, Child mortality), **Education** (Years of schooling, School attendance), and **Living Standards** (Cooking fuel, Sanitation, Water, Electricity, Floor, Assets). * **Poverty Line in India:** Traditionally based on **calorie intake** (2400 kcal in rural, 2100 kcal in urban areas) or monthly per capita expenditure (Tendulkar/Rangarajan Committee).
Explanation: ### Explanation In Health Economics, **Cost-Benefit Analysis (CBA)** is a unique evaluative technique where both the inputs (costs) and the outcomes (benefits) of a health program are measured in **monetary units (e.g., Dollars or Rupees)**. This allows policy makers to calculate the "Net Present Value" or the "Benefit-Cost Ratio" to determine if an investment is worthwhile. **Why "Monetary gains" is correct:** CBA translates health outcomes—such as cases prevented or lives saved—into a dollar value. This allows for a direct comparison between health programs and non-health sectors (e.g., comparing the benefit of building a hospital versus building a highway). If the monetary benefit exceeds the cost, the program is considered economically viable. **Analysis of Incorrect Options:** * **A. Number of lives saved:** This is the hallmark of **Cost-Effectiveness Analysis (CEA)**. In CEA, costs are in money, but benefits are measured in physical units (e.g., lives saved, years of life gained, or cases averted). * **C. Comparison of alternatives:** While all economic evaluations involve comparing alternatives, this is a general feature of the field, not the specific unit of measurement for benefits in CBA. * **D. Sequence of actions:** This refers to operational planning or "Network Analysis" (like PERT or CPM), which deals with the timing and order of project activities rather than economic valuation. **High-Yield Pearls for NEET-PG:** 1. **Cost-Effectiveness Analysis (CEA):** Most common in health; results expressed as "Cost per life saved." 2. **Cost-Benefit Analysis (CBA):** Most difficult to perform because it is hard to put a price on human life; results expressed as a "Ratio." 3. **Cost-Utility Analysis (CUA):** A specialized form of CEA where benefits are measured in **Quality-Adjusted Life Years (QALYs)** or DALYs. 4. **Cost-Minimization Analysis (CMA):** Used when two interventions have identical outcomes, so you simply choose the cheapest one.
Explanation: ### Explanation **1. Why the Correct Answer is Right:** In health economics, the term **"Net"** always refers to the value remaining after subtracting **Capital Consumption** (also known as **Depreciation**). * **Gross National Product (GNP)** is the total market value of all final goods and services produced by the residents of a country in a given period. * However, during production, machinery, equipment, and infrastructure undergo wear and tear (depreciation). * When you subtract this depreciation from the Gross value, you arrive at the **Net National Product (NNP)**. * **Formula:** $NNP = GNP - \text{Depreciation (Capital Consumption)}$ **2. Why the Other Options are Incorrect:** * **B. Gross Domestic Product (GDP):** This measures production within a country's geographical boundaries, regardless of the nationality of the producers. It does not account for capital consumption. * **C. Gross National Income (GNI):** This is essentially equivalent to GNP; it measures the total income earned by a nation's people and businesses, including investment income, regardless of where it was earned. * **D. Net Domestic Product (NDP):** This is $GDP - \text{Depreciation}$. It focuses on domestic production minus wear and tear, whereas the question asks for the net value of the *National* product. **3. High-Yield Clinical Pearls for NEET-PG:** * **NNP at Factor Cost** is the most accurate measure of **National Income**. * **Purchasing Power Parity (PPP):** A method used to compare the standard of living between countries by eliminating differences in price levels. * **Per Capita Income:** Total National Income divided by the total population. It is a key indicator used by the World Bank to classify countries (Low, Middle, and High income). * **Physical Quality of Life Index (PQLI):** Includes Infant Mortality Rate (IMR), Life Expectancy at age 1, and Literacy. (Note: It does *not* include Income/GNP).
Explanation: ### Explanation **Correct Answer: D. Cost-benefit analysis** **Why it is correct:** In **Cost-Benefit Analysis (CBA)**, both the inputs (costs) and the outcomes (benefits) are measured in **monetary terms** (e.g., Dollars or Rupees). This allows for a direct comparison of the economic benefits of a program against its costs. If the benefit-to-cost ratio is greater than one, the program is considered economically viable. It is the gold standard for deciding whether to invest in a specific health program versus a non-health sector (e.g., building a hospital vs. building a highway). **Why the other options are incorrect:** * **A. Cost-accounting analysis:** This is a purely financial process of documenting and tracking every expenditure incurred during the delivery of a service. It does not measure outcomes or benefits. * **B. Input-output analysis:** This evaluates the relationship between the resources put into a system (inputs like manpower, money) and the immediate products generated (outputs like number of immunizations given). It does not necessarily assign a monetary value to the long-term benefit. * **C. Cost-effectiveness analysis (CEA):** This is the most common analysis in healthcare. Here, costs are measured in money, but benefits are measured in **natural units** (e.g., years of life saved, number of cases prevented, or mm Hg reduction in BP). It compares different ways to achieve the same goal but does not provide a "monetary" benefit. **High-Yield Clinical Pearls for NEET-PG:** * **Cost-Utility Analysis (CUA):** A specialized form of CEA where outcomes are measured in "quality-adjusted life years" (**QALYs**) or "disability-adjusted life years" (**DALYs**). * **Key Distinction:** If the question mentions "monetary value" or "economic benefit" for outcomes $\rightarrow$ **CBA**. If it mentions "lives saved" or "clinical units" $\rightarrow$ **CEA**. * **Efficiency:** Health economics primarily aims to achieve "allocative efficiency"—doing the most good with limited resources.
Explanation: ### Explanation In Health Economics, evaluating the relationship between resources spent and outcomes achieved is crucial for public health planning. **Why "Cost Accounting" is the correct answer:** Cost accounting (also known as **Cost-Analysis**) is the simplest form of economic evaluation. It involves the systematic process of identifying, recording, and summarizing all expenditures incurred in a health program. In this specific context, the "benefit" is expressed directly in terms of the **results achieved** (e.g., the number of vaccinations given, the number of cataract surgeries performed, or the number of health education sessions conducted) relative to the total expenditure. It measures the internal efficiency of a program. **Analysis of Incorrect Options:** * **A. Cost-Benefit Analysis (CBA):** Here, both the costs and the outcomes (benefits) are measured in **monetary terms** (e.g., dollars or rupees). It is used to compare programs across different sectors (e.g., health vs. education). * **B. Cost-Effective Analysis (CEA):** This measures the outcome in **natural units** or physical improvements (e.g., "years of life saved" or "reduction in blood pressure"). It is used to compare two different interventions for the same disease. * **D. Cost Containment:** This refers to strategies aimed at controlling or reducing health expenditures without compromising the quality of care. **High-Yield Clinical Pearls for NEET-PG:** * **Cost-Utility Analysis (CUA):** A specialized form of CEA where the outcome is measured in **Quality Adjusted Life Years (QALYs)** or **Disability Adjusted Life Years (DALYs)**. * **Input:** Refers to resources (money, manpower, materials). * **Output:** Refers to the immediate result (services rendered). * **Impact:** Refers to the long-term effect on health status (reduction in mortality/morbidity).
Explanation: ### Explanation **Correct Answer: C. Cost analysis** In the context of health management and economics, **Cost analysis** is considered the most fundamental and cost-effective method for managing a project. It involves the systematic evaluation of resources (inputs) consumed in terms of monetary value to achieve a specific outcome. By identifying where money is spent and comparing it against the budget, managers can ensure fiscal discipline and resource optimization without requiring the complex mathematical modeling or extensive data collection associated with other systems. **Why other options are incorrect:** * **Network analysis (e.g., PERT/CPM):** This is a tool for **time management** and scheduling. While it helps in identifying the "critical path" of a project to avoid delays, it is a specialized technique rather than a general method for cost-effective management. * **System analysis:** This is a broad, holistic approach used for **decision-making** and problem-solving. It looks at the interaction of various components within an organization. While comprehensive, it is often resource-intensive and complex, making it less "cost-effective" as a standalone management tool compared to direct cost analysis. * **Field analysis:** This typically refers to social or environmental assessments (often used in sociology or community health research). It is not a standard economic tool for project management. **High-Yield Clinical Pearls for NEET-PG:** * **Cost-Benefit Analysis (CBA):** Benefits are measured in **monetary terms** (e.g., dollars saved). * **Cost-Effectiveness Analysis (CEA):** Benefits are measured in **natural units** (e.g., lives saved, cases prevented). * **Cost-Utility Analysis (CUA):** Benefits are measured in **Quality Adjusted Life Years (QALYs)**. This is the most sophisticated form of CEA. * **Input-Output Analysis:** A method used to assess the relationship between the resources put into a program and the final products/services generated.
Explanation: ### Explanation In Health Economics, different types of evaluations are used to compare the inputs (costs) and outputs (consequences) of healthcare interventions. **1. Why Cost-Effective Analysis (CEA) is correct:** Cost-Effective Analysis is the most common evaluation method used in public health. In CEA, the **costs are measured in monetary units** (e.g., Rupees or Dollars), but the **benefits are expressed in natural units** or "results achieved." Examples of these results include "life years gained," "number of cases prevented," or "reduction in blood pressure (mmHg)." It helps decision-makers choose the intervention that provides the most clinical "bang for the buck." **2. Why the other options are incorrect:** * **Cost-Benefit Analysis (CBA):** In CBA, both the costs and the benefits are expressed in **monetary terms**. This allows for a direct comparison of different sectors (e.g., comparing a health program to a road construction project). * **Cost Accounting:** This is a purely administrative process of calculating the total expenditure involved in providing a service. It does not measure the health outcomes or benefits achieved. * **Cost Containment:** This refers to strategies or policies aimed at controlling or reducing the growth of healthcare expenditures without necessarily focusing on the measurement of outcomes. **3. High-Yield Clinical Pearls for NEET-PG:** * **Cost-Utility Analysis (CUA):** A specialized form of CEA where the outcome is measured in terms of "quality of life," typically expressed as **QALYs** (Quality Adjusted Life Years) or **DALYs** (Disability Adjusted Life Years). * **Input vs. Output:** In health economics, "Input" refers to resources (money, staff, time), while "Output" refers to the service provided or the health status change. * **DALY (Disability Adjusted Life Year):** One DALY represents the loss of the equivalent of one year of full health. It is the sum of Years of Life Lost (YLL) and Years Lived with Disability (YLD).
Explanation: ### Explanation **Gross Domestic Product (GDP)** is the correct answer because it represents the total monetary value of all finished goods and services produced **within a country's specific geographical boundaries** over a specific period (usually a year). In health economics, GDP is a critical indicator of a nation’s economic health and its capacity to fund public health infrastructure and social security. **Analysis of Incorrect Options:** * **Net National Product (NNP):** This is the Gross National Product (GNP) minus depreciation. It accounts for the income of all citizens (including those abroad) but subtracts the wear and tear on assets. * **Net Domestic Product (NDP):** This is GDP minus depreciation. While it focuses on income within the country, it is a "net" measure, not the total "gross" income generated. * **Purchasing Power Parity (PPP):** This is an economic theory and metric used to compare the buying power of different currencies. It allows economists to compare the standard of living between countries by adjusting for the cost of goods (e.g., the "International Dollar"). **High-Yield Clinical Pearls for NEET-PG:** * **Health Expenditure:** In India, the National Health Policy (2017) aims to increase government health spending to **2.5% of the GDP** by 2025. * **GDP vs. GNP:** Remember the "Geographical" rule: **G**DP = **G**eographical boundary; **G**NP = **N**ationality (citizens, regardless of where they live). * **PQLI vs. HDI:** The Physical Quality of Life Index (PQLI) **does not** include GNP/GDP, whereas the Human Development Index (HDI) **does** include GNI (Gross National Income) per capita.
Explanation: ### Explanation The core of this question lies in distinguishing between **Health Status Indicators** and **Socio-economic Indicators**. **Why "Life Expectancy at Birth" is the correct answer:** Life expectancy at birth is a **Mortality Indicator**, which falls under the broader category of **Health Status Indicators**. It measures the quality of life and the effectiveness of the healthcare system in a country. While socio-economic factors influence it, the indicator itself directly reflects the health outcome (mortality) rather than a social or economic condition. **Analysis of Incorrect Options:** * **Dependency Ratio (Option A):** This is a classic socio-economic indicator. It represents the ratio of the "dependent" population (those under 15 and over 65 years) to the "working-age" population (15–64 years). It reflects the economic burden on the productive members of society. * **Family Size (Option B):** This is a social indicator. Large family sizes, especially in low-income settings, are often correlated with lower per capita resource availability, affecting nutrition and education. * **Level of Unemployment (Option C):** This is a direct economic indicator. Unemployment leads to poverty, poor housing, and mental stress, all of which are social determinants that influence health. **High-Yield NEET-PG Pearls:** * **Socio-economic Indicators include:** Rate of population increase, Per capita GNP, Level of unemployment, Dependency ratio, Literacy rate (especially female literacy), Family size, and Housing (e.g., persons per room). * **Health Status Indicators include:** * **Mortality Indicators:** IMR, U5MR, Maternal Mortality Ratio, Life expectancy. * **Morbidity Indicators:** Incidence, Prevalence, Notification rates. * **Disability Indicators:** Sullivan’s Index, DALY (Disability Adjusted Life Years). * **Sullivan’s Index:** Calculated as Life expectancy minus duration of bed disability/inability to perform major activities. It is considered the most appropriate indicator of "Positive Health."
Explanation: ### Explanation In Health Economics, different types of evaluation methods are used to compare the inputs (costs) and outputs (consequences) of health programs. **1. Why Cost-Benefit Analysis (CBA) is correct:** In **Cost-Benefit Analysis**, both the costs incurred and the resulting benefits are measured in **monetary units (e.g., Dollars or Rupees)**. This allows for a direct comparison of the economic value of a program. If the monetary benefit exceeds the cost, the program is considered economically viable. It is the only method that allows for the comparison of programs across different sectors (e.g., comparing a vaccination program to a road safety project). **2. Why the other options are incorrect:** * **Cost-Effective Analysis (CEA):** Here, costs are measured in monetary terms, but the outcomes are measured in **natural units** (e.g., number of lives saved, cases prevented, or reduction in blood pressure). It compares different ways of achieving the same objective. * **Cost Accounting:** This is a purely internal financial process used to track the actual expenditure and resources consumed during a project. It does not measure the "benefits" or outcomes of the program. * **Network Analysis:** This is a management tool (e.g., PERT, CPM) used for planning and scheduling complex projects to identify the most efficient sequence of activities. It is not an economic evaluation method. ### High-Yield Clinical Pearls for NEET-PG: * **Cost-Utility Analysis (CUA):** A specialized form of CEA where outcomes are measured in terms of "quality of life," typically using **QALYs** (Quality Adjusted Life Years) or **DALYs** (Disability Adjusted Life Years). * **Input:** Always measured in money (Cost). * **Output Measurement Summary:** * **CBA:** Money * **CEA:** Natural units (e.g., lives saved) * **CUA:** QALYs/DALYs (Quality of life)
Explanation: ### Explanation **1. Why Cost-Effective Analysis (CEA) is Correct:** In health economics, **Cost-Effective Analysis (CEA)** is used to compare different interventions by measuring their costs in monetary units (e.g., Rupees/Dollars) against their outcomes in **natural health units** or "results achieved." These results are non-monetary and specific to the clinical goal, such as "number of lives saved," "cases of malaria prevented," or "reduction in blood pressure (mmHg)." It helps administrators decide which intervention provides the "most bang for the buck" without needing to put a price tag on human life. **2. Analysis of Incorrect Options:** * **Cost-Benefit Analysis (CBA):** Here, both costs and benefits are measured in **monetary terms** (money). It calculates the "Return on Investment." If the benefit-to-cost ratio is >1, the project is considered worthwhile. * **Cost-Accounting:** This is a purely internal management tool used to calculate the total cost of providing a specific service (e.g., the cost of one appendectomy). It does not measure health outcomes or "results achieved." * **System Analysis:** This is a broad management technique used to study a complex system (like a hospital) to improve efficiency and decision-making. It is not a specific economic evaluation of health benefits. **3. High-Yield Clinical Pearls for NEET-PG:** * **Cost-Utility Analysis (CUA):** A specialized form of CEA where the result is measured in **Quality-Adjusted Life Years (QALYs)** or **Disability-Adjusted Life Years (DALYs)**. * **Input vs. Output:** In health economics, "Input" refers to resources (money, manpower), while "Output" refers to the results (lives saved, cures). * **CEA vs. CBA:** Remember, **CEA** uses natural units (Results), while **CBA** uses currency (Money).
Explanation: **Explanation:** **1. Why Cost-Effectiveness Analysis (CEA) is correct:** Cost-effectiveness analysis is used to compare the costs and health outcomes of one or more interventions. In CEA, the outcomes are measured in **natural health units** (e.g., number of deaths prevented, years of life saved, cases diagnosed, or reduction in blood pressure). Since the question specifically asks for the evaluation of "deaths prevented" (a natural unit), CEA is the most appropriate tool. It helps decision-makers determine which intervention provides the maximum health improvement for a given level of expenditure. **2. Why other options are incorrect:** * **Cost-Benefit Analysis (CBA):** In CBA, both the costs and the outcomes are measured in **monetary terms** (e.g., dollars or rupees). It is used to determine if the financial gain of a program outweighs its cost. It does not measure outcomes in natural units like "deaths prevented." * **Cost Accounting:** This is a purely financial process used to track and analyze the internal costs of providing a service. It focuses on the "input" (expenditure) rather than the "outcome" or impact of a health program. **3. High-Yield Clinical Pearls for NEET-PG:** * **Cost-Utility Analysis (CUA):** A specialized form of CEA where outcomes are measured in terms of quality of life, most commonly **QALYs** (Quality-Adjusted Life Years) or **DALYs** (Disability-Adjusted Life Years). * **Cost-Minimization Analysis (CMA):** Used when two interventions have **equal outcomes**, and the goal is simply to find the least expensive option. * **Input vs. Output:** In health economics, money spent is the "input," while health improvements (like deaths prevented) are the "output."
Explanation: **Explanation:** **Cost-effectiveness analysis (CEA)** is the correct answer because it compares the costs of an intervention to its outcomes measured in **natural health units** (e.g., number of deaths prevented, life years gained, or cases averted). In this scenario, "deaths prevented" is a physical, non-monetary outcome, making CEA the most appropriate tool for evaluation. **Analysis of Options:** * **Cost-benefit analysis (CBA):** This method measures both the costs and the outcomes (benefits) in **monetary terms** (e.g., dollars or rupees). It is used to determine if the financial return of a program exceeds its cost. Since "deaths prevented" is not a currency value, CBA is incorrect. * **Cost accounting:** This is a management process used to track and analyze the internal costs of providing a specific service or product. It focuses on expenditure rather than evaluating health outcomes or program impact. **High-Yield NEET-PG Pearls:** * **Cost-Utility Analysis (CUA):** A specialized form of CEA where outcomes are measured in terms of quality of life, most commonly **QALYs** (Quality-Adjusted Life Years) or **DALYs** (Disability-Adjusted Life Years). * **Cost-Minimization Analysis (CMA):** Used when two interventions have **equal outcomes**, and the goal is simply to find the least expensive option (e.g., comparing a generic vs. brand-name drug). * **Input vs. Output:** In health economics, "Input" refers to resources (money, staff), while "Output" refers to the health results achieved.
Explanation: ***5%***- The **World Health Organization (WHO)** recommends that countries aim to spend at least **5%** of their **Gross Domestic Product (GDP)** or **Gross National Product (GNP)** on health.- This minimum threshold is deemed necessary to establish basic **universal health coverage** and ensure robust primary healthcare services.*2.0%*- Spending only **2.0%** of GNP is drastically low and associated with poor health outcomes and high rates of **out-of-pocket expenses** for citizens.- This level of allocation is insufficient to fund essential public health functions or maintain a functional **healthcare system**.*2.5%*- While slightly better than 2.0%, **2.5%** remains well below the recognized international benchmark required for adequate health investment.- This level fails to provide resources for comprehensive care, including preventative services and necessary **infrastructure development**.*3.5%*- Allocating **3.5%** shows some governmental commitment but still falls short of the WHO's target for sustainable and effective health financing.- The shortfall between 3.5% and 5% often represents a gap in funding for critical areas like **health workforce training** and access to specialized care.
Explanation: ***Infant mortality rate*** - The Human Development Index (HDI) focuses on broader measures of human well-being, specifically **health, education, and living standards**. - While reflecting a nation's health status, the **infant mortality rate** is not a direct component used in the HDI calculation. *Gross national income per capita* - **Gross national income (GNI) per capita** is a key component of the HDI, reflecting the **standard of living** dimension. - It measures the average income of a country's citizens and contributes to a country's overall development score. *Life expectancy at birth* - **Life expectancy at birth** is a crucial component of the HDI, representing the **health** dimension. - It indicates the average number of years a newborn infant can expect to live, given current mortality rates. *Mean years of schooling* - **Mean years of schooling** is a core component of the HDI, reflecting the **education** dimension. - It measures the average number of years of education received by people aged 25 and older.
Explanation: ***Cost benefit analysis*** - In **cost-benefit analysis**, the **benefits of a program** are quantified in monetary terms and then compared directly with the **monetary cost** of the program. - This method is used to determine if the **monetary gain (or benefit)** from a program outweighs its monetary expenditure. *Cost effective analysis* - **Cost-effectiveness analysis** compares the **costs of alternative programs** with their effectiveness, usually measured in natural units suitable for the health outcome (e.g., lives saved, cases cured). - It does not assign a monetary value to the health outcome but rather identifies the intervention that achieves the **desired outcome at the lowest cost** or the maximum outcome for a given cost. *Management by objectives* - **Management by objectives (MBO)** is a strategic management model that aims to improve organizational performance by clearly defining objectives that are agreed to by both management and employees. - This concept is primarily about **setting goals and tracking performance** within an organization, not about analyzing program costs versus outcomes. *Cost utility study* - A **cost-utility analysis (CUA)** is a type of cost-effectiveness analysis where the health outcome is measured in **quality-adjusted life years (QALYs)** or disability-adjusted life years (DALYs). - It accounts for both the **quantity and quality of life**, but it still does not express benefits in direct monetary terms.
Explanation: ***Correct: High risk selective screening*** - **High-risk selective screening** is the **most cost-effective** strategy for cervical cancer screening as it targets populations with higher disease prevalence - Focuses resources on women at increased risk: age 30-65 years, multiple sexual partners, early sexual debut, HPV exposure, immunocompromised status, low socioeconomic status - **Maximizes detection yield per rupee spent** by concentrating efforts where disease probability is highest - Aligns with **WHO recommendations** and national guidelines for resource-limited settings - Better **cost-benefit ratio** compared to screening the entire population including low-risk groups *Incorrect: Mass screening* - Mass screening involves screening the **entire population** regardless of risk factors - While it may identify more total cases, it is **not cost-effective** as it expends resources on large low-risk populations - The question specifically asks for "**most cost-effective**" approach, not maximum coverage - In resource-limited settings (relevant for India), targeted screening provides better value *Incorrect: Multiphasic screening* - Refers to using **multiple screening tests** simultaneously for different diseases - Increases complexity and cost when applied to multiple conditions - Not specifically addressing cost-effectiveness for **single disease** (cervical cancer) screening *Incorrect: Prospective screening* - This term typically refers to **research methodology** involving forward-looking cohort studies - Not a standard classification of population screening strategies - More resource-intensive and used in research settings rather than routine public health programs
Explanation: ***Cost effectiveness analysis*** - This method uses **mathematical and statistical techniques** to compare the costs and health outcomes of different interventions, making it a quantitative approach. - It involves calculating metrics like the **incremental cost-effectiveness ratio (ICER)** to guide resource allocation decisions. *Communication management* - This involves strategies for **effective information exchange** within an organization and with external stakeholders, which is primarily a qualitative process. - While it can be measured (e.g., surveys), the core activity is not based on numerical data analysis for direct health outcomes. *Human Resource Management* - This focuses on managing an organization's **workforce**, including staffing, training, and performance evaluation. - It's mainly a qualitative and administrative function, although some aspects like budgeting for salaries might involve quantitative data. *Supportive supervision and leadership* - This involves **guiding and motivating staff** to achieve organizational goals and improve performance. - These are primarily **qualitative skills** and management styles, focusing on interpersonal interactions and team building.
Explanation: ***Wealth index*** - The **National Family Health Survey-III (NFHS-III)** used a **wealth index** as a primary measure to assess the economic status of households. - This index is a composite measure derived from household assets and housing characteristics. *Lifestyle index* - The term "lifestyle index" is a general concept and was not the specific, officially recognized tool for measuring economic status in NFHS-III. - While lifestyle aspects can be indicators of economic status, they are typically integrated into broader indices like the wealth index rather than being a standalone measure in this context. *Pareek scale* - The **Pareek scale** was not used in NFHS-III for measuring household economic status. - The Pareek scale is a socio-economic status scale that primarily focuses on **occupational prestige** and education, and it is less commonly used for national health surveys in India compared to asset-based indices. *Kuppuswamy's scale* - **Kuppuswamy's Socioeconomic Status Scale** was not used in the NFHS-III survey. - This scale is an older and more commonly used tool in clinical and research settings within India, but it primarily classifies families based on **education** and **occupation** of the head of the family, and family income.
Explanation: **0.667** - The Life Expectancy Index (LEI) is a component of the Human Development Index (HDI). - Formula: **LEI = (Actual Life Expectancy - Minimum Life Expectancy) / (Maximum Life Expectancy - Minimum Life Expectancy)** - Calculation: (64 - 20) / (86 - 20) = 44 / 66 = **0.667** - The index ranges from 0 to 1, where higher values indicate better life expectancy relative to the reference range. *0.512* - This value would result from calculation errors, such as using incorrect minimum or maximum values. - For example, if a different denominator was used or if the actual life expectancy was miscalculated. *0.970* - This value is too high and suggests a calculation error. - An index of 0.970 would indicate the country's life expectancy is 84 years (very close to the maximum of 86 years). *0.744* - This value does not correspond to the given parameters. - Could result from arithmetic errors or using different reference values for minimum/maximum life expectancy. - Using the correct formula with given values yields 0.667, not 0.744.
Explanation: ***Human developmental index*** - The **Human Development Index (HDI)** is the correct answer as the diagram exactly represents its three core dimensions - HDI measures overall achievement in: **Health** (life expectancy at birth), **Education** (mean years of schooling and expected years of schooling), and **Living standards** (GNI per capita) - These are the standard components published by UNDP for calculating HDI - HDI is a summary measure of average achievement in key dimensions of human development *Human poverty index* - The Human Poverty Index (HPI) was an older measure that has been discontinued - HPI focused on deprivations rather than overall development achievements - The diagram shows development indicators (positive achievements), not deprivation indicators - HPI has been replaced by the Multidimensional Poverty Index (MPI) *POLI* - **POLI** (Physical Quality of Life Index) is a different index that uses infant mortality, life expectancy at age one, and literacy rate - The components shown in the diagram (mean years of schooling, expected years of schooling, GNI per capita) are not part of POLI - This is not a recognized standard index in current use *Multidimensional poverty index* - The **Multidimensional Poverty Index (MPI)** measures acute multidimensional poverty across health, education, and living standards - However, MPI uses **different specific indicators**: nutrition, child mortality, years of schooling, school attendance, cooking fuel, sanitation, drinking water, electricity, housing, and assets - The diagram shows HDI components (life expectancy, mean/expected years of schooling, GNI per capita), which are NOT the MPI indicators - MPI focuses on deprivations at the household level, while the diagram shows aggregate development measures
Explanation: ***Integration with HIV services*** - This approach offers the **highest return on investment** for national STI control programs as it leverages existing infrastructure and funding for HIV services, maximizing resource utilization. - **Syndromic management of STIs integrated with HIV care** allows for efficient screening, diagnosis, and treatment of both conditions simultaneously, reaching high-risk populations effectively. - **India's National AIDS Control Programme (NACP)** successfully demonstrates this model, with STI/RTI services integrated into HIV testing and counseling centers, reducing duplication and operational costs. - **WHO guidelines strongly recommend** this integration strategy as the most cost-effective approach for national STI control programs, particularly in resource-limited settings. *Mobile testing units* - While helpful for reaching underserved populations, **mobile units have high operational costs** including staffing, vehicle maintenance, and equipment, which significantly limit their overall return on investment. - Their effectiveness is often localized and may not provide broad, sustainable impact across an entire national program compared to integrated services. *Online partner notification* - This method's reach is limited by **digital literacy and access barriers**, potentially excluding high-risk groups without internet access, particularly relevant in the Indian context. - While it can improve partner tracing in certain populations, the initial setup costs and limited universal applicability reduce its overall cost-effectiveness compared to integrated clinical services. *Mass media campaigns* - These campaigns require **significant financial investment** for broadcast time and creative development, with outcomes that are difficult to quantify in terms of direct STI reduction. - While effective for raising general awareness, they generate less measurable return on investment for direct STI control services compared to targeted clinical interventions like integrated service delivery.
Explanation: ***Cost benefit analysis*** - This method evaluates both the **costs** and **benefits** of a project or intervention in **monetary terms**. - It is the **only economic evaluation method** that expresses **both costs AND outcomes (benefits) in monetary units**. - This allows for a direct comparison of the financial value of benefits against the financial value of costs to determine overall worth and calculate net benefit or benefit-cost ratio. *Network analysis* - **Network analysis** is a quantitative method that focuses on relationships or connections between entities. - It is primarily used for understanding **structures and patterns** in complex systems (like disease transmission networks), not for direct monetary valuation. - This is **not an economic evaluation method**. *Cost minimization analysis* - This method compares only the **costs** of two or more interventions that are proven to have **equivalent outcomes or effectiveness**. - While it deals with costs in monetary terms, it **does not express benefits/outcomes in monetary units** - it simply assumes they are equal. - The primary goal is to identify the **least expensive option** among equally effective alternatives, not to monetize outcomes.
Explanation: ***1.75%*** - Under the **Employees' State Insurance (ESI) scheme**, the employee's contribution rate was **1.75% of their monthly wages** (prior to 2019 amendment) [1]. - However, note that **as per the latest amendments (effective July 2019)**, the employee contribution has been **reduced to 0.75%** and employer contribution to 3.25%. - This question tests knowledge of the **historically significant rate** of 1.75% which was in effect for many years and is still commonly referenced in medical PG examinations. *4.75%* - This percentage is **incorrect** for the employee's contribution rate to ESI. - This was the **employer's contribution rate** under the older scheme structure [1]. *3.75%* - This figure is **not a standard ESI employee contribution rate**. - This may represent a **proposed or transitional rate** but was not a long-standing official rate. *2.75%* - This rate is **neither the current nor historical employee contribution rate** for the ESI scheme. - This does not correspond to any **standard ESI contribution structure**.
Explanation: ***A level of blindness that prevents an individual from earning a livelihood*** - **Economic blindness** refers to the degree of vision impairment severe enough to render an individual unable to perform economically productive tasks. - This definition emphasizes the **socioeconomic impact** of vision loss rather than the clinical severity alone. *Blindness that is expensive to treat* - This option describes **costly treatments** for blindness, which is a different aspect of healthcare economics. - While treatment costs can be a burden, they do not define the concept of economic blindness itself. *Blindness affecting only economically disadvantaged populations* - While **disadvantaged populations** may have a higher prevalence of blindness, economic blindness can affect individuals from any socioeconomic background if their vision loss prevents them from working. - This option incorrectly limits the scope of economic blindness to a specific demographic. *Blindness due to economic factors like malnutrition* - This option describes the **etiology** or cause of blindness (e.g., malnutrition due to poverty). - While economic factors can certainly lead to vision impairment, **economic blindness** refers to the functional impact of blindness on an individual's ability to earn a living, not its cause.
Explanation: ***QALYs gained*** - **Quality-Adjusted Life Years (QALYs)** is the most comprehensive measure in cost-effectiveness analysis as it accounts for both the quantity and quality of life - Combines years of life added with a utility score reflecting health-related quality of life during those years - Provides a holistic view that captures both mortality and morbidity benefits of interventions *Number of heart attacks avoided* - Specific to a single clinical outcome and does not account for other health benefits or adverse effects - While important for cardiovascular interventions, it is too narrow to serve as a comprehensive cost-effectiveness indicator - Does not capture broader impact on overall health, quality of life, or longevity *Cost per life year gained* - Focuses on the quantity (length) of life gained but does not consider the quality of those gained years - An intervention might add years of life that are of poor quality, which this measure cannot differentiate - Less comprehensive than QALYs as it misses the health status dimension *Number of life years gained* - Only considers the extension of life without incorporating health status or quality of life during additional years - Provides an incomplete picture as it treats all life years equally regardless of health state - A longer life with significant disability would be valued the same as healthy years
Explanation: ***Mean years of schooling and expected years of schooling are used to calculate the education index*** - The **education index** in the HDI is a composite of **mean years of schooling** (for adults aged 25 and older) and **expected years of schooling** (for children of school-entering age) - This approach provides a comprehensive measure of both **past educational attainment** and **future educational opportunities** - The two indices are combined using a **geometric mean** to create the overall education index *1/3rd weightage is given to adult literacy* - While adult literacy was a component of the **original HDI education index (pre-2010)**, it has been replaced by mean years of schooling for a more nuanced measure - The current methodology focuses on actual and expected years of formal education rather than simple literacy rates *In gross enrolment, only secondary education is considered, not primary education* - The HDI utilizes **expected years of schooling**, which incorporates **all levels of education**, including primary, secondary, and tertiary - It does not selectively consider only secondary education for gross enrollment *2/3rd weightage is given to gross enrollment* - In the **old HDI methodology (pre-2010)**, adult literacy rate had 2/3rd weightage and gross enrollment ratio had 1/3rd weightage - In the **current HDI**, the education component is calculated using the **geometric mean** of two equally weighted normalized indices: the mean years of schooling index and the expected years of schooling index - There is no longer a 2/3rd weightage system in the current methodology
Explanation: ***Infant mortality*** - The **Human Poverty Index (HPI)** focuses on deprivation in basic dimensions of human life including longevity, knowledge, and standard of living. While infant mortality reflects health and living conditions, it is not a direct component used in calculating the HPI. - Instead, the HPI uses other indicators like **probability at birth of not surviving to age 40** (for HPI-1) or **probability at birth of not surviving to age 60** (for HPI-2) to measure deprivation in longevity. *Knowledge* - **Deprivation in knowledge** is a core component of the HPI, typically measured by the **adult illiteracy rate**. - This indicator assesses the lack of basic education and the inability to participate fully in society. *Standard of living* - **Deprivation in standard of living** is another key dimension, measured by a composite of several factors. - These typically include the **percentage of people without access to safe water**, the **percentage of people without access to health services**, and the **percentage of underweight children under five years of age**. *Longevity* - **Deprivation in longevity** is a fundamental pillar of the HPI, indicating the vulnerability to death at an early age. - It is measured by the **probability at birth of not surviving to age 40** (HPI-1) or **probability at birth of not surviving to age 60** (HPI-2).
Explanation: ***975 Rs*** - As per the **Employees' State Insurance (ESI) Act** (current rates effective from July 2019), the employer's contribution rate is **3.25% of the total wages** paid. - For a monthly wage bill of Rs 30,000, the employer's ESI contribution would be 3.25% of 30,000 = **Rs 975**. - The total ESI contribution (employer + employee) is **4.00%**, with employer paying 3.25% and employee paying 0.75%. *1425 Rs* - This value was based on the **old employer contribution rate of 4.75%** (before July 2019). - The current rate is **3.25%**, making this amount incorrect under the present ESI Act provisions. *5000 Rs* - This value is significantly higher than the statutory employer contribution rate under the **ESI Act**. - It represents approximately **16.67%** of wages, which is far above the actual rate. *2000 Rs* - This amount exceeds the standard **3.25% employer contribution** specified by the ESI Act. - It represents approximately **6.67%** of the monthly wage bill, which does not align with current statutory rates.
Explanation: ***Cost-effective analysis*** - **Cost-effective analysis** compares interventions by relating their costs to a single, common health outcome measured in **natural units** (e.g., years of life saved, cases cured, or blood pressure reduced). - This method helps identify the most efficient way to achieve a specific health outcome when the benefits cannot be readily monetized. *Program budgeting system* - A **program budgeting system** is a management tool used to allocate resources to achieve specific program objectives, typically expressing costs in monetary units. - It focuses on grouping expenditures by program rather than by traditional line items, but does not inherently measure *benefits* in natural units. *Network analysis* - **Network analysis** (e.g., PERT/CPM) is a project management technique used for planning, scheduling, and controlling complex projects by identifying critical paths and potential delays. - It primarily deals with time, resources, and dependencies, not the measurement of health benefits in natural units. *Cost-benefit analysis* - **Cost-benefit analysis** (CBA) values both the costs and benefits of an intervention in **monetary terms**, allowing for direct comparison and a societal perspective. - While comprehensive, it differs from CEA by requiring all benefits, including health outcomes, to be translated into a common monetary unit.
Explanation: ***QALY*** - **Quality-Adjusted Life Years (QALYs)** combine the length of life with the **quality of life** lived, taking into account healthcare utility values (e.g., from 0 for dead to 1 for perfect health). - An increase in life expectancy due to healthcare advancements, coupled with assumed utility values, directly enables the calculation of QALYs gained or lost. *HALE* - **Health-Adjusted Life Expectancy (HALE)** is a measure of the average number of years that a person can expect to live in "**full health**" by adjusting for years lived in less than full health due to disease or injury. - While it incorporates health status, it specifically focuses on time lived in full health rather than the utility-weighted quality of life over the entire lifespan as QALYs do. *DALY* - **Disability-Adjusted Life Years (DALYs)** measure the total number of healthy years lost due to disease, disability, or premature death. - DALYs are a measure of disease burden, quantifying years lost, whereas QALYs are a measure of health gains or health states. *DFLE* - **Disability-Free Life Expectancy (DFLE)** measures the expected number of years an individual will live without disability. - While it considers the absence of disability, it does not incorporate the concept of "utility values" or varying degrees of health-related quality of life beyond a binary disabled/non-disabled state, as QALYs do.
Explanation: ***Cost-effectiveness analysis*** - In **cost-effectiveness analysis**, the benefits of a healthcare intervention are measured in **natural units** (e.g., lives saved, years of life gained, cases cured, reduction in symptoms). - This method compares the costs of different interventions to achieve a specific health outcome, expressed in a non-monetary unit. *Network analysis* - **Network analysis** is a project management technique used to plan and control complex projects, often for scheduling tasks and identifying critical paths. - Its primary focus is on task dependencies and timelines, not on measuring benefits of management interventions in natural units. *Cost-benefit analysis* - In **cost-benefit analysis**, both the costs and the benefits of an intervention are converted into **monetary units**. - This allows for a comparison where a project is deemed beneficial if its monetary benefits outweigh its monetary costs. *Program budgeting system* - A **program budgeting system** is a financial planning and management tool that links expenditures to the achievement of specific program objectives. - While it focuses on resource allocation and outcomes, it does not primarily measure benefits in natural health units.
Explanation: ***Environmental sustainability*** - Environmental sustainability is not directly included as a component in the standard HDI calculation. - While it's a critical aspect of development, the HDI focuses specifically on health, education, and living standards. *Income* - **Income** as a component of the HDI is represented by Gross National Income (GNI) per capita (PPP $). - This indicator reflects the standard of living and purchasing power within a country. *Knowledge* - The **knowledge** component of the HDI is measured by mean years of schooling and expected years of schooling. - This aims to reflect the level of education and human capital in a country. *Longevity* - **Longevity** is measured by life expectancy at birth. - This component assesses the health and well-being of a population.
Explanation: ***ABC analysis*** - **ABC analysis** classifies inventory items into three categories (A, B, and C) based on their annual consumption value, identifying a small percentage of items that account for most of the expenditure. - **Category A** items are high-value and high-priority (typically 10-20% of items accounting for 70-80% of expenditure), while **Category C** items are low-value and low-priority (50-70% of items accounting for 5-10% of expenditure), fitting the description of a small number of high-value items and a large number of low-value items. - Based on the **Pareto principle (80/20 rule)** in inventory management. *SUS analysis* - **SUS analysis** categorizes items based on their **procurement characteristics**: **Scarce** (difficult to procure), **Urgent** (needed immediately), and **Seasonal** (required at specific times). - It focuses on availability and timing of procurement rather than expenditure or consumption value. - Does not classify items by their monetary value or identify high vs. low-value items. *HML analysis* - **HML analysis** categorizes items based on their **unit price** (High, Medium, Low), not their total expenditure or annual consumption value. - While it considers value, it doesn't prioritize items by the total financial impact or identify the expenditure pattern described in the question. *VED analysis* - **VED analysis** classifies inventory items based on their **criticality** (Vital, Essential, Desirable) for operational needs, particularly in healthcare where stockouts can have severe consequences. - It focuses on the importance of an item for function and patient care, rather than its monetary expenditure or value.
Explanation: ***Finance Commission*** - The **Finance Commission** is a constitutional body in India whose primary role is to recommend the distribution of **financial resources** between the union and state governments, including those allocated to the health sector. - Its recommendations cover **tax devolution**, grants-in-aid, and measures to improve the **financial health** of states, which directly impacts health sector funding. *Department of Expenditure in the Union Government* - While the **Department of Expenditure** manages government spending, it operates within the framework of recommendations made by the Finance Commission regarding resource distribution. - Its role is to **implement** and manage the approved budgetary allocations rather than to independently recommend the division of financial resources between the center and states. *Inter–State Council* - The **Inter-State Council** is constituted to investigate and discuss subjects of common interest between the Union and states, or among states, and to make recommendations for **better coordination** of policy and action. - It does not primarily deal with the **distribution of financial resources** but rather with issues of cooperation and policy harmonization. *Planning Commission* - The **Planning Commission** (now replaced by NITI Aayog) was responsible for formulating five-year plans and allocating resources based on these plans. - Although it played a role in guiding resource allocation, it did not have the constitutional mandate to recommend the **fundamental formula** for sharing financial resources between the center and states, which is the purview of the Finance Commission.
Basic Concepts in Health Economics
Practice Questions
Health Financing Mechanisms
Practice Questions
Cost-Benefit Analysis
Practice Questions
Cost-Effectiveness Analysis
Practice Questions
Health Insurance Systems
Practice Questions
National Health Accounts
Practice Questions
Healthcare Market Analysis
Practice Questions
Economic Evaluation of Health Programs
Practice Questions
Resource Allocation in Healthcare
Practice Questions
Direct and Indirect Health Costs
Practice Questions
Health Budget Planning
Practice Questions
Economic Burden of Disease
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free